Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In The Dafo Injection Solution Atc L04Aa23 For The Period 09 01 24 08 31 26 Conclusion Of A Non E

Deadline: 03 Dec 2026

Germany

Ref. No.: 30448636

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In The Dafo Injection Solution Atc L04Aa23 For The Period 09 01 24 08 31 26 Conclusion Of A Non E

Deadline: 03 Dec 2026

Germany

Ref. No.: 30448634

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In The Dafo Injection Solution Atc L04Aa23 For The Period 09 01 24 08 31 26 Conclusion Of A Non E

Deadline: 03 Dec 2026

Denmark

Ref. No.: 30448633

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In The Dafo Injection Solution Atc L04Aa23 For The Period 09 01 24 08 31 26 Conclusion Of A Non E

Deadline: 03 Dec 2026

Germany

Ref. No.: 30448632

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Framework Agreement Medals Framework Agreement Medals

Deadline: 03 Dec 2026

Sweden

Ref. No.: 30446799

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 F D Z 01 09 24 31 08 26 Conclusion Of A Non Exc

Deadline: 03 Dec 2026

Netherlands

Ref. No.: 30446469

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 F D Z 01 09 24 31 08 26 Conclusion Of A Non Exc

Deadline: 03 Dec 2026

Germany

Ref. No.: 30446468

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 F D Z 01 09 24 31 08 26 Conclusion Of A Non Exc

Deadline: 03 Dec 2026

Germany

Ref. No.: 30446467

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 F D Z 01 09 24 31 08 26 Conclusion Of A Non Exc

Deadline: 03 Dec 2026

Germany

Ref. No.: 30446466

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 F D Z 01 09 24 31 08 26 Conclusion Of A Non Exc

Deadline: 03 Dec 2026

Germany

Ref. No.: 30446465

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 F D Z 01 09 24 31 08 26 Conclusion Of A Non Exc

Deadline: 03 Dec 2026

Germany

Ref. No.: 30446463

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 F D Z 01 09 24 31 08 26 Conclusion Of A Non Exc

Deadline: 03 Dec 2026

Denmark

Ref. No.: 30446460

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Pin 2026 09 026 Supply And Delivery Of Various Engineering Maintenance Supply

Deadline: 15 Oct 2026

Philippines

Ref. No.: 30432486

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Olanzapine Excl Dafo For The Production Of A Depot Isu Atc N05Ah03 F D 01 08 24 31 07 26 Conclusion Of A Non Exclus

Deadline: 02 Dec 2026

Netherlands

Ref. No.: 30432198

EMD:Ref Document

Bid Value: Ref Document

50 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Olanzapine Excl Dafo For The Production Of A Depot Isu Atc N05Ah03 F D 01 08 24 31 07 26 Conclusion Of A Non Exclus

Deadline: 02 Dec 2026

Denmark

Ref. No.: 30432195

EMD:Ref Document

Bid Value: Ref Document

50 Days Left

Discover Tenders by Iris Recognition Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Iris Recognition Sector

Filter Your Search

FREE Trial plan for all new users!